Drugs resources

A summary of the major items discussed at the first MDAF meeting.

A summary of the major items discussed at the second MDAF meeting.

A summary of the major items discussed at the third MDAF meeting.

A summary of the major items discussed at the fifth MDAF meeting.

A summary of the major items discussed at the fourth MDAF meeting.

A Budget 2022–23 fact sheet.

This strategy aims to reduce the use and harmful effects of ice in Australia.

This report presents the final evaluation findings, covering the pilot in NSW, SA and WA from commencement on 1 December 2019 up until 30 June 2021.

An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2020 to 30 June 2021.

This strategy aims to improve the skills of the alcohol and other drug (AOD) workforce and prepare them for the future.

An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2019 to 30 June 2020.

This document is a response to the findings of the National Ice taskforce in 2015. This report provides a comprehensive assessment of the NIAS.

This report outlines the findings of a randomised controlled trial (RCT) conducted by the Department of Health. The RCT explored whether a letter designed with behavioural insights principles would help GPs reflect on their opioid prescribing.

The Real Time Prescription Monitoring (RTPM) Privacy Impact Assessment (PIA) was conducted to ensure the Nation Data Exchange (NDE) system contained the appropriate obligations and protections in relation to the collection and storage of individual personal information.

This certificate of compliance, signed by Secretary Brendan Murphy, certifies that the safe and effective prescription opioids campaign complies with relevant guidelines and policies.

This framework’s aim is that all Australians seeking alcohol and other drug treatment can access high quality treatment appropriate to their needs, when and where they need it. It includes principles for effective treatment, monitoring and evaluation.

This report presents trends data of the Australian Secondary Students' Alcohol and Drug (ASSAD) survey. It includes statistics on the use of tobacco, alcohol, electronic cigarettes, over-the-counter drugs, and illicit drugs, 1996–2017.

This report presents the results of the Australian Secondary Students’ Alcohol and Drug (ASSAD) survey. It includes statistics on the use of tobacco, alcohol, electronic cigarettes, over-the-counter drugs, and illicit drugs.

This Annual Report is consistent with the National Drug Strategy 2017–2026.

This 2014 report describes the alcohol and other drug (AOD) treatment system and funding processes in Australia. It provides options for future funding that respond to the needs of individuals, families and communities.

An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2018 to 30 June 2019.

This framework sets a nationally consistent quality benchmark for providers of drug and alcohol treatment services. It includes strong clinical governance requirements and a list of accreditation standards that drug and alcohol specialist treatment service providers must meet.

An overview of activities by the Australian National Advisory Council on Alcohol and Other Drugs (ANACAD) from 1 July 2017 to 30 June 2018.